Dr Kenichiro Shimokawa

KANDO id: 40955

Bio

Dr Shimokawa joined AVM in March 2011. Prior to joining AVM, Dr. Shimokawa served as an Associate Director at Department of Licensing & Alliances, Astellas Pharma Inc since October 2010. He was involved M&A of Japanese Biotech Company, a license-in deal opportunity as well as evaluation of a couple of license-in opportunities. During 2006-2010, He served as a Global Project Leader (“GPL”) for CNS and bone therapeutic area at Project Management, Development, Astellas Pharma Inc. He brought “Bonoteo” for osteoporosis drug in Japanese market, as well as staged up a couple of compounds to P2/3, P1 and P0 in US/EU/JP. Prior to the GPL, he served as a medicinal and combinatorial chemist to synthesize number of compounds for various therapeutic areas, especially for CNS, Pain and Cardiovascular. Dr Shimokawa received a PhD in Chemistry from the University of Pennsylvania.

Education